Ico Therapeutics Inc (ICO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65 | 990 | 10 | 1,128 | 2,361 |
| Receivables | 449 | 414 | 130 | 88 | 37 |
| TOTAL | $543 | $1,462 | $175 | $1,374 | $2,424 |
| Non-Current Assets | |||||
| PPE Net | 3 | 6 | 3 | 2 | 3 |
| Investments And Advances | N/A | N/A | N/A | 0 | 3 |
| Intangibles | N/A | N/A | N/A | 0 | 22 |
| TOTAL | $3 | $6 | $3 | $2 | $28 |
| Total Assets | $546 | $1,468 | $178 | $1,376 | $2,452 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,075 | 659 | 706 | 255 | 62 |
| Accrued Expenses | 222 | 149 | 96 | 33 | 76 |
| TOTAL | $1,297 | $808 | $803 | $288 | $138 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,297 | $808 | $803 | $288 | $138 |
| Shareholders' Equity | |||||
| Common Shares | 29,769 | 29,769 | 28,048 | 0 | 0 |
| Retained earnings | -38,471 | -36,983 | -35,044 | -33,342 | -32,104 |
| Other shareholders' equity | 1,410 | 1,428 | 2,088 | 2,853 | 2,853 |
| TOTAL | $-750 | $661 | $-625 | $1,087 | $2,314 |
| Total Liabilities And Equity | $546 | $1,468 | $178 | $1,376 | $2,452 |